Skip to content

Author

R. Nichols

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

rVSV-ΔG-EBOV-GP-Nipah-G (also designated PHV02) replication-competent, recombinant vesicular stomatitis virus vaccine for prevention of Nipah virus disease: Standardized template with key considerations for a risk/benefit assessment.

A recombinant vesicular stomatitis virus (rVSV) expressing the glycoprotein (GP) of Ebola virus (rVSV-EBOV GP) has been approved for preventive immunization against Ebola (Ervebo®, Merck & Co.). The rVSV-EBOV vector was modified to express an additional glycoprotein (G) of Nipah virus (NiV), a bat-borne henipavirus end...

Thomas P. Monath, J. Fusco, Emily Erbelding et al. · 0 citations
Open access Sep 2026

Immunological Correlate of Protection by PHV02 Live, Attenuated Recombinant VSV Vaccine Against Nipah Virus Disease Using an Improved Neutralizing Antibody Method, with Considerations for Future Research

Establishing the immune correlate of protection for a vaccine could be the basis for regulatory approval. The immune correlate of PHV02, a clinical-stage recombinant vesicular stomatitis (rVSV) vaccine against Nipah virus (NiV) disease, was investigated in the African green monkey (AGM) model. Although a mechanistic im...

Thomas P. Monath, R. Nichols, W. Rida et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.